A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Mehnert, Janice M.; Silk, Ann W.; Wen, Yu; Lee, J. H.; Dudek, Liesel; Jeong, Byeong-Seon; Li, Jiadong; Schenkel, Jason M.; Sadimin, Evita; Kane, Michael; Lin, Hongxia; Shih, Weichung J.; Zloza, Andrew; Chen, Suzie; Goydos, James. S.

期刊名称Pigment Cell & Melanoma Research
作者Mehnert, Janice M.; Silk, Ann W.; Wen, Yu; Lee, J. H.; Dudek, Liesel; Jeong, Byeong-Seon; Li, Jiadong; Schenkel, Jason M.; Sadimin, Evita; Kane, Michael; Lin, Hongxia; Shih, Weichung J.; Zloza, Andrew; Chen, Suzie; Goydos, James. S.
印刷ISSN1755-1471
文件大小905.57KB
发表时间2018-02-17
DOI10.1111/pcmr.12694

发现好书期刊，享受阅读乐趣

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma